Cargando…
Clinical factors associated with weight loss outcomes after Roux-en-Y gastric bypass surgery
OBJECTIVE: Gastric bypass surgery is an effective therapy for extreme obesity. However, substantial variability in weight loss outcomes exists that remains largely unexplained. Our objective was to determine whether any commonly collected pre-operative clinical variables were associated with weight...
Autores principales: | Still, Christopher D., Wood, G. Craig, Chu, Xin, Manney, Christina, Strodel, William, Petrick, Anthony, Gabrielsen, Jon, Mirshahi, Tooraj, Argyropoulos, George, Seiler, Jamie, Yung, Marco, Benotti, Peter, Gerhard, Glenn S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3819407/ https://www.ncbi.nlm.nih.gov/pubmed/23804287 http://dx.doi.org/10.1002/oby.20529 |
Ejemplares similares
-
An electronic health record-enabled obesity database
por: Wood, G Craig, et al.
Publicado: (2012) -
All-Cause and Specific-Cause Mortality Risk After Roux-en-Y Gastric Bypass in Patients With and Without Diabetes
por: Lent, Michelle R., et al.
Publicado: (2017) -
A Role for Fibroblast Growth Factor 19 and Bile Acids in Diabetes Remission After Roux-en-Y Gastric Bypass
por: Gerhard, Glenn S., et al.
Publicado: (2013) -
A Patient-Centered Electronic Tool for Weight Loss Outcomes after Roux-en-Y Gastric Bypass
por: Wood, G. Craig, et al.
Publicado: (2014) -
CCL20 is up-regulated in non-alcoholic fatty liver disease fibrosis and is produced by hepatic stellate cells in response to fatty acid loading
por: Chu, Xin, et al.
Publicado: (2018)